The ITN is currently seeking Concept Proposals for novel clinical trials designed to induce immune tolerance in Type 1 Diabetes, transplantation, autoimmune diseases, and allergy and asthma. In addition the ITN accepts applications for the development of novel tolerance assays or mechanistic studies for the purposes of establishing new surrogate biomarkers of immune tolerance and investigating the mechanisms of clinical tolerance. Proposals should be submitted via our site: http://www.immunetolerance.org/professionals/proposals/guidelines
Detailed information and instructions: RFP - Clinical Trials in Immune Tolerance
-------------------
The Immune Tolerance Network (ITN) is seeking ‘Proposal Outlines' for novel clinical trials designed to induce immune tolerance in psoriasis and other autoimmune skin disorders, including those mediated by autoantibodies such as pemphigus and pemphigoid.
DEADLINE: 30 August 2009
Detailed information and instructions: ITN_Psoriasis_RFP_2009.08.30.pdf
-------------------Request for Expressions of Interest for Innovative Clinical Trials in Type 1 Diabetes
The purpose of this EOI is to gather information from the scientific community about novel ideas for tolerogenic immunotherapeutic trials in type 1 diabetes (T1D). Expressions of interest should be submitted as attached pdf files via e-mail to Philip Bernstein (pbernstein@immunetolerance.org) under the subject line “EOI-Innovative T1D Trials” no later than April 13, 2009 at noon EST.
> Download pdf [72 kb]
